Search

Your search keyword '"Lupus"' showing total 299 results

Search Constraints

Start Over You searched for: Descriptor "Lupus" Remove constraint Descriptor: "Lupus" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
299 results on '"Lupus"'

Search Results

1. The SLE‐associated TREX1‐P212fs mutation disrupts ER association leading to type I interferonopathy.

2. Combined Pediatric Rheumatology/Dermatology Clinics: Benefits and Challenges.

Catalog

Books, media, physical & digital resources

3. Multifaceted Proteome Analysis at Solubility, Redox, and Expression Dimensions for Target Identification.

4. Comparison of pregnancy outcomes between indigenous and non‐indigenous lupus patients.

5. Intersection of the microbiome and immune metabolism in lupus.

6. Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases.

7. Comorbidities associated with discoid lupus erythematosus: A case–control study in the All of Us Research Program.

8. Systemic correlates of cutaneous manifestations of lupus erythematosus.

9. Harnessing cGAS–STING axis for therapeutic benefits in systemic lupus erythematosus.

10. Rapidly progressing pediatric Lupus with Diffuse Alveolar Hemorrhage and CNS involvement.

11. Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.

12. Acute digital ischemia due to lupus vasculitis successfully treated with anifrolumab.

13. It feels like lupus: accessible science for the low‐vision community on immune system dysfunction in lupus.

14. B cell pathway dual inhibition for systemic lupus erythematosus: a prospective single‐arm cohort study of telitacicept.

15. Trends in and outcomes of delivery hospitalizations with lupus and antiphospholipid syndrome.

16. Epigenetic mechanisms driving the pathogenesis of systemic lupus erythematosus, systemic sclerosis and dermatomyositis.

17. Association between pyoderma gangrenosum and autoimmune connective tissue disorders: A systematic review.

18. Presumptive phenobarbital‐induced systemic lupus erythematosus in a domestic dog.

19. Clinical significance of antinuclear antibodies in primary immune thrombocytopenia.

20. The use of belimumab in three cases of refractory lupus nephritis.

21. Cancer development in patients hospitalized with systemic lupus erythematosus: A population‐level data linkage study.

22. T‐bet‐expressing B cells contribute to the autoreactive plasma cell pool in Lyn‐/‐ mice.

23. Neonatal lupus erythematosus presenting as a non‐bullous histiocytoid neutrophilic dermatosis.

24. Organizing pneumonia as an initial presentation in a male lupus: A rare case report.

25. Lupus anticoagulant hypoprothrombinemia syndrome: A case report.

26. A common mechanism links Epstein‐Barr virus infections and autoimmune diseases.

27. A decreased number of circulating regulatory T cells is associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.

28. Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements.

30. Increased levels of sirtuin‐1 in systemic lupus erythematosus.

31. Anti‐tumour necrosis factor‐α‐induced lupus in a patient receiving infliximab for sarcoidosis.

32. Anticancer treatments and photosensitivity.

33. Fulminant lupus pneumonitis complicating systemic lupus erythematosus in the elderly.

34. Emerging role of TWEAK‐Fn14 axis in lupus, a disease related to autoimmunity and fibrosis.

35. Maternal exposure to hydroxychloroquine and birth defects.

36. Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements.

37. Hydroxychloroquine does not impair antibody response to 13‐valent pneumococcal conjugate vaccine in patients with cutaneous lupus erythematosus—A pilot study.

39. Neonatal lupus erythematosus presenting as orolabial ulcerations: Two cases and a review of the literature.

40. Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects.

41. The role of neuraminidase in TLR4‐MAPK signalling and the release of cytokines by lupus serum‐stimulated mesangial cells.

42. Discoid lupus erythematosus of the palms: A case report.

43. Intestinal pseudo‐obstruction: Unusual presentation of systemic lupus erythematous.

44. Bcl‐3 inhibits lupus‐like phenotypes in BL6/lpr mice.

45. ISG15 protects human Tregs from interferon alpha‐induced contraction in a cell‐intrinsic fashion.

46. CC chemokine receptor 6 (CCR6) in the pathogenesis of systemic lupus erythematosus.

47. IL‐38: A novel cytokine in systemic lupus erythematosus pathogenesis.

48. Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus.

49. A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans.

50. Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.